US Doubles Spending on Potential Covid-19 Vaccine to Nearly $1 Bn, Final Phase of Trials Begins Today

Moderna said the added investment was justified by its decision, in conjunction with the government, to "significantly" expand a Phase Three clinical trial of a candidate vaccine to include 30,000 participants.

https://ift.tt/30Gj4Zr
https://ift.tt/30TjXOo